The Clorox Company (NYSE:CLX) Shares Acquired by ABLE Financial Group LLC

ABLE Financial Group LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX) by 8.3% during the third quarter, Holdings Channel.com reports. The fund owned 3,389 shares of the company’s stock after acquiring an additional 261 shares during the period. ABLE Financial Group LLC’s holdings in Clorox were worth $552,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of CLX. Nordea Investment Management AB raised its holdings in shares of Clorox by 4.5% in the first quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock worth $1,519,000 after buying an additional 426 shares during the last quarter. Central Pacific Bank Trust Division purchased a new position in Clorox in the 1st quarter worth $88,000. Texas Permanent School Fund Corp lifted its position in Clorox by 1.8% during the 1st quarter. Texas Permanent School Fund Corp now owns 25,636 shares of the company’s stock worth $3,925,000 after acquiring an additional 455 shares during the period. Advisory Services Network LLC grew its stake in Clorox by 5.2% during the 1st quarter. Advisory Services Network LLC now owns 20,515 shares of the company’s stock valued at $3,141,000 after purchasing an additional 1,008 shares during the last quarter. Finally, Empirical Finance LLC increased its holdings in shares of Clorox by 3.5% in the first quarter. Empirical Finance LLC now owns 4,457 shares of the company’s stock valued at $682,000 after purchasing an additional 152 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.57% of the stock is currently owned by insiders.

Clorox Price Performance

Shares of Clorox stock traded up $0.99 on Friday, reaching $163.76. The company’s stock had a trading volume of 243,299 shares, compared to its average volume of 1,239,719. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $20.27 billion, a P/E ratio of 56.74, a PEG ratio of 3.02 and a beta of 0.41. The stock has a 50-day moving average price of $161.89 and a 200-day moving average price of $146.58. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.49 EPS. Analysts expect that The Clorox Company will post 6.81 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 2.98%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 170.04%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. DA Davidson lifted their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a report on Wednesday. Evercore ISI reduced their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Finally, Barclays lifted their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.